171 related articles for article (PubMed ID: 7875668)
1. Transjugular intrahepatic portosystemic shunts for refractory ascites: assessment of clinical and hormonal response and renal function.
Somberg KA; Lake JR; Tomlanovich SJ; LaBerge JM; Feldstein V; Bass NM
Hepatology; 1995 Mar; 21(3):709-16. PubMed ID: 7875668
[TBL] [Abstract][Full Text] [Related]
2. Predictors of clinical response to transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients with refractory ascites.
Deschênes M; Dufresne MP; Bui B; Fenyves D; Spahr L; Roy L; Lafortune M; Pomier-Layrargues G
Am J Gastroenterol; 1999 May; 94(5):1361-5. PubMed ID: 10235219
[TBL] [Abstract][Full Text] [Related]
3. Transjugular intrahepatic portal-systemic shunt in the treatment of refractory ascites: effect on clinical, renal, humoral, and hemodynamic parameters.
Quiroga J; Sangro B; Núñez M; Bilbao I; Longo J; García-Villarreal L; Zozaya JM; Betés M; Herrero JI; Prieto J
Hepatology; 1995 Apr; 21(4):986-94. PubMed ID: 7705810
[TBL] [Abstract][Full Text] [Related]
4. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
[TBL] [Abstract][Full Text] [Related]
5. Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome.
Wong F; Pantea L; Sniderman K
Hepatology; 2004 Jul; 40(1):55-64. PubMed ID: 15239086
[TBL] [Abstract][Full Text] [Related]
6. Renal effects of transjugular intrahepatic portosystemic shunt in cirrhosis: comparison of patients with ascites, with refractory ascites, or without ascites.
Gerbes AL; Gülberg V; Waggershauser T; Holl J; Reiser M
Hepatology; 1998 Sep; 28(3):683-8. PubMed ID: 9731559
[TBL] [Abstract][Full Text] [Related]
7. Long-term renal sodium handling in patients with cirrhosis treated with transjugular intrahepatic portosystemic shunts for refractory ascites.
Wong W; Liu P; Blendis L; Wong F
Am J Med; 1999 Mar; 106(3):315-22. PubMed ID: 10190381
[TBL] [Abstract][Full Text] [Related]
8. Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage.
Sahagun G; Benner KG; Saxon R; Barton RE; Rabkin J; Keller FS; Rosch J
Am J Gastroenterol; 1997 Sep; 92(9):1444-52. PubMed ID: 9317060
[TBL] [Abstract][Full Text] [Related]
9. Transjugular intrahepatic portosystemic shunt for refractory ascites: an analysis of the literature on efficacy, morbidity, and mortality.
Russo MW; Sood A; Jacobson IM; Brown RS
Am J Gastroenterol; 2003 Nov; 98(11):2521-7. PubMed ID: 14638358
[TBL] [Abstract][Full Text] [Related]
10. Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems.
Guevara M; Ginès P; Bandi JC; Gilabert R; Sort P; Jiménez W; Garcia-Pagan JC; Bosch J; Arroyo V; Rodés J
Hepatology; 1998 Aug; 28(2):416-22. PubMed ID: 9696006
[TBL] [Abstract][Full Text] [Related]
11. Transjugular intrahepatic portosystemic shunts in hemodialysis-dependent patients and patients with advanced renal insufficiency: safety, caution, and encephalopathy.
Haskal ZJ; Radhakrishnan J
J Vasc Interv Radiol; 2008 Apr; 19(4):516-20. PubMed ID: 18375295
[TBL] [Abstract][Full Text] [Related]
12. Transjugular intrahepatic portosystemic shunts for refractory ascites after liver transplantation.
Abouljoud M; Yoshida A; Kim D; Jerius J; Arenas J; Raoufi M; Brown K; Moonka D
Transplant Proc; 2005 Mar; 37(2):1248-50. PubMed ID: 15848685
[TBL] [Abstract][Full Text] [Related]
13. Correlation between portal/hepatic vein gradient and response to transjugular intrahepatic portosystemic shunt creation in refractory ascites.
Nair S; Singh R; Yoselewitz M
J Vasc Interv Radiol; 2004 Dec; 15(12):1431-4. PubMed ID: 15590801
[TBL] [Abstract][Full Text] [Related]
14. Differences in long-term survival after transjugular intrahepatic portosystemic shunt for refractory ascites and variceal bleed.
Membreno F; Baez AL; Pandula R; Walser E; Lau DT
J Gastroenterol Hepatol; 2005 Mar; 20(3):474-81. PubMed ID: 15740494
[TBL] [Abstract][Full Text] [Related]
15. Correlation between increased colloid osmotic pressure and the resolution of refractory ascites after transjugular intrahepatic portosystemic shunt.
Schiano TD; Black M; Hills C; Ter H; Bellary S; Miller LS
South Med J; 2000 Mar; 93(3):305-9. PubMed ID: 10728519
[TBL] [Abstract][Full Text] [Related]
16. Surgical shunts and TIPS for variceal decompression in the 1990s.
Henderson JM; Nagle A; Curtas S; Geisinger M; Barnes D
Surgery; 2000 Oct; 128(4):540-7. PubMed ID: 11015086
[TBL] [Abstract][Full Text] [Related]
17. Transjugular intrahepatic portosystemic stent shunt: effects on hemodynamics and sodium homeostasis in cirrhosis and refractory ascites.
Wong F; Sniderman K; Liu P; Allidina Y; Sherman M; Blendis L
Ann Intern Med; 1995 Jun; 122(11):816-22. PubMed ID: 7741365
[TBL] [Abstract][Full Text] [Related]
18. Transjugular intrahepatic portosystemic shunts in liver transplant recipients.
Kim JJ; Dasika NL; Yu E; Fontana RJ
Liver Int; 2008 Feb; 28(2):240-8. PubMed ID: 18251981
[TBL] [Abstract][Full Text] [Related]
19. Predictors of mortality and stenosis after transjugular intrahepatic portosystemic shunt.
Russo MW; Jacques PF; Mauro M; Odell P; Brown RS
Liver Transpl; 2002 Mar; 8(3):271-7. PubMed ID: 11910573
[TBL] [Abstract][Full Text] [Related]
20. Transjugular intrahepatic portosystemic shunt: efficacy for the treatment of portal hypertension and impact on liver transplantation.
Cosenza CA; Hoffman AL; Friedman ML; Sher LS; Lopez RR; Van Allen R; Brown DH; Fraiman MH; Arnaout W; Vierling J; Makowka L
Am Surg; 1996 Oct; 62(10):835-9. PubMed ID: 8813166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]